The rotator cuff study was presented at the Orthopaedic Research Society Annual Meeting, Feb. 2-5 in Austin, Texas. Highlighting the results of a dose ranging study, the presentation gave insight into how the study used MRI and histopathology to compare the results of Ortho-R versus standard care options.
Results showed Ortho-R improved rotator cuff healing processes in a large animal model. The study will be published in the Journal of Tissue Engineering and Regenerative Medicine.
Ortho RTi has produced 16 peer-reviewed abstracts, posters, manuscripts and podium presentations in the last two years on its various technologies.
More articles on biologics:
ThermoGenesis makes orthopedic partnership: 3 notes
CDC investigates contaminated stem cell products: 5 things to know
Global spine biologics market to hit $2.7B by 2024 — 18 key players
